Acute hypertensive transfusion reactions

Laboratory Medicine

Volumn 37, Issue 9, 2006, Pages 542-545

  Bruno, Debora Santos ^a   Herman, Jay H ^a  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 12; BRADYKININ; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

BLOOD FILTER; BLOOD PRESSURE; BLOOD STORAGE; BLOOD TRANSFUSION REACTION; DIALYSIS MEMBRANE; ENDOTHELIUM; ENZYME METABOLISM; HUMAN; HYPOTENSION; PATHOPHYSIOLOGY; PROTEIN BINDING; REVIEW;

EID: 33748940609     PISSN: 00075027     EISSN: None     Source Type: Journal    
DOI: 10.1309/PCARYBE0RVAFKDDK     Document Type: Review

References (20)

1. Popovsky MA. Transfusion reactions. Bethesda, MD: AABB Press; 2001: 222.
2. Kaplan AP, Joseph K, Shibayama Y, et al. Bradykinin formation. Plasma and tissue pathways and cellular interactions. Clin Rev Allergy Immunol. 1998;16:403-429.
3. Cyr M, Eastlund T, Blais C, et al. Bradykinin metabolism and hypotensive transfusion reactions. Transfusion. 2001;41:136-150.
4. Alving BM, Hojima Y, Pisano JJ, et al. Hypotension associated with prekallikrein activator (Hageman-factor fragments) in plasma protein fraction. N Engl J Med. 1978;299:66-70.
5. Van Roosevelt RF, Bakker JC, Sinclair DM, et al. Bradykinin-mediated hypotension after infusion of plasma-protein fractions. J Lab Clin Med. 1982;100:288-295.
6. Adverse reactions to platelet transfusions reported. Blood Bank Week. 1993;10:1-2.
7. Hume HA, Popovsky MA, Benson K. Hypotensive reactions: a previously uncharacterized complication of platelet transfusion? Transfusion. 1996;36:904-909.
8. Takahashi TA, Abe H, Hosoda M, et al. Bradykinin generation during filtration of platelet concentrates with a white cell-reduction filter. Transfusion. 1995;35:967.
9. Shiba M, Tadokoro K, Sawanobori M, et al. Activation of the contact system by filtration of platelet concentrates with a negatively charged white cell-removal filter and measurement of venous blood bradykinin level in patients who received filtered platelets. Transfusion. 1997;37:457-462.
10. Sweeney JD, Dupuis M, Mega AJ. Hypotensive reactions to red cells filtered at the bedside, but not to those filtered before storage, in patients taking ACE inhibitors. Transfusion. 1998;38:410-411.
11. Abe H, Ikebuchi K, Shimbo M, et al. Hypotensive reactions with a white cell-reduction filter: activation of kallikrein-kinin cascade in a patient. Transfusion. 1998;38:411-412.
12. Belloni M, Alghisi A, Bettini C, et al. Hypotensive reactions associated with white cell-reduced apheresis platelet concentrates in patients not receiving ACE inhibitors. Transfusion. 1998;38:412-413.
13. Fried MR, Eastlund T, Christie B, et al. Hypotensive reactions to white cell-reduced plasma in a patient undergoing angiotensin-converting enzyme inhibitor therapy. Transfusion. 1996;36:900-903.
14. Yenicesu I, Tezcan I, Tuncer AM. Hypotensive reactions during platelet transfusions. Transfusion. 1998;38:410-411.
15. Cyr M, Hume HA, Champagne M, et al. Anomaly of the des-Arg9-bradykinin metabolism associated with severe hypotensive reactions during blood transfusion: a preliminary report. Transfusion. 1999;39:1084-1088.
16. Arnold DM, Molinaro G, Warkentin TE, et al. Hypotensive transfusion reactions can occur with blood products that are leukoreduced before storage. Transfusion. 2004;44:1361-1366.
17. 9-bradykinin after contact activation. Transfusion. 2002;42:1458-1465.
18. Owen HG, Brecher ME. Atypical reactions associated with use of angiotensin-converting enzyme inhibitors and apheresis. Transfusion. 1994;34:891-894.
19. Kroon AA, Mol MJ, Stalenhoef AF. ACE inhibitors and LDL-apheresis with dextran sulphate adsorption. Lancet. 1992;340:1476.
20. 9- bradykinin metabolism in patients who presented hypersensitivity reactions during hemodialysis: role of serum ACE and aminopeptidase P. Peptides. 1999;20:421-430.